Contrast-enhanced ultrasound identifies early extrahepatic collateral contributing to residual hepatocellular tumor viability after transarterial chemoembolization by Sriharsha Gummadi, MD, Maria Stanczak, MS, RDMS, RVT, Andrej Lyshchik, MD, PhD, Flemming Forsberg, PhD, Colette M. Shaw, MD, John R. Eisenbrey, PhD

Get full text